Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 6171.57 | 21 / 21 | 100% | 53.29 | 504 / 504 |
intestine | 100% | 6761.01 | 966 / 966 | 100% | 49.30 | 527 / 527 |
pancreas | 100% | 3360.77 | 328 / 328 | 100% | 46.48 | 178 / 178 |
skin | 100% | 7362.47 | 1809 / 1809 | 100% | 68.31 | 472 / 472 |
thymus | 100% | 6511.09 | 653 / 653 | 100% | 55.30 | 605 / 605 |
uterus | 100% | 7660.99 | 170 / 170 | 100% | 62.41 | 459 / 459 |
prostate | 100% | 7092.38 | 245 / 245 | 100% | 51.52 | 501 / 502 |
liver | 100% | 3233.23 | 226 / 226 | 100% | 30.90 | 405 / 406 |
stomach | 100% | 4782.70 | 359 / 359 | 100% | 41.19 | 285 / 286 |
adrenal gland | 100% | 5338.67 | 258 / 258 | 100% | 44.28 | 229 / 230 |
breast | 100% | 6505.09 | 459 / 459 | 99% | 51.06 | 1112 / 1118 |
esophagus | 100% | 5867.50 | 1445 / 1445 | 99% | 36.93 | 182 / 183 |
kidney | 100% | 4917.61 | 89 / 89 | 99% | 35.67 | 896 / 901 |
brain | 100% | 5513.69 | 2639 / 2642 | 99% | 60.15 | 701 / 705 |
lung | 100% | 6596.48 | 578 / 578 | 99% | 44.28 | 1146 / 1155 |
ovary | 100% | 7257.42 | 180 / 180 | 99% | 27.53 | 426 / 430 |
adipose | 100% | 6048.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 70.56 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 83.18 | 29 / 29 |
muscle | 100% | 6508.90 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8226.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 61.92 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 42.63 | 1 / 1 |
blood vessel | 100% | 5757.06 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 5674.28 | 919 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 4000.01 | 851 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0050684 | Biological process | regulation of mRNA processing |
GO_0030520 | Biological process | estrogen receptor signaling pathway |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0030496 | Cellular component | midbody |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003723 | Molecular function | RNA binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | SAFB |
Protein name | Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein) SAFB protein Scaffold attachment factor B |
Synonyms | HAP HET SAFB1 |
Description | FUNCTION: Binds to scaffold/matrix attachment region (S/MAR) DNA and forms a molecular assembly point to allow the formation of a 'transcriptosomal' complex (consisting of SR proteins and RNA polymerase II) coupling transcription and RNA processing . Functions as an estrogen receptor corepressor and can also bind to the HSP27 promoter and decrease its transcription . Thereby acts as a negative regulator of cell proliferation . When associated with RBMX, binds to and stimulates transcription from the SREBF1 promoter (By similarity). . |
Accessions | Q15424 ENST00000589863.5 K7ES42 B7ZLP5 ENST00000592224.5 [Q15424-4] K7EII0 ENST00000589006.1 ENST00000588852.2 [Q15424-3] ENST00000292123.9 [Q15424-1] ENST00000454510.5 [Q15424-2] |